Quality of life in patients with proton-treated pediatric medulloblastoma: Results of a prospective assessment with 5-year follow-up.
Sophia C KamranSaveli I GoldbergKaren A KuhlthauMiranda P LawellElizabeth A WeymanSara L GallottoClayton B HessMary S HuangAlison M FriedmannAnnah N AbramsShannon M MacDonaldMargaret B PulsiferNancy J TarbellDavid H EbbTorunn I YockPublished in: Cancer (2018)
HRQOL scores appear to increase over time after treatment in children treated with proton RT for medulloblastoma but remain lower compared with those of parent-proxy reports as well as published means from a healthy normative sample of children. Additional follow-up may translate into continued improvements in HRQOL. Cancer 2018. © 2018 American Cancer Society.